Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/14/2017 02/15/2017 02/16/2017 02/17/2017 02/21/2017 Date
69.63(c) 69.46(c) 69.23(c) 69.97(c) 71.37(c) Last
3 696 195 6 935 203 3 143 068 2 716 030 4 550 083 Volume
+0.48% -0.24% -0.33% +1.07% +2.00% Change
More quotes
Financials ($)
Sales 2017 102 522 M
EBIT 2017 6 749 M
Net income 2017 2 970 M
Debt 2017 11 594 M
Yield 2017 -
Sales 2018 105 813 M
EBIT 2018 6 855 M
Net income 2018 3 041 M
Debt 2018 10 582 M
Yield 2018 -
P/E ratio 2017 14,09
P/E ratio 2018 12,37
EV / Sales2017 0,53x
EV / Sales2018 0,51x
Capitalization 43 230 M
More Financials
Company
Express Scripts Holding Co. engages in the provision of integrated pharmacy benefit management services.Its services include network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, benefit-design consultation, drug utilization review, formulary management, and... 
Sector
Drug Retailers
Calendar
05/02Earnings Release
More about the company
Surperformance© ratings of Express Scripts Holding Co
Trading Rating : Investor Rating :
More Ratings
Latest news on EXPRESS SCRIPTS HOLDING CO
02/17 EXPRESS SCRIPTS : CEO addresses drug pricing "misinformation"
02/16 EXPRESS SCRIPTS : Fights Back Against Irresponsible Drug Pricing; Holds U.S. Dru..
02/15 EXPRESS SCRIPTS HOLDING COMPANY (NAS : ESRX) Files An 8-K Results of Operations ..
02/14 EXPRESS SCRIPTS : Management's Discussion and Analysis of Financial Condition an..
02/14DJEXPRESS SCRIPTS : Revenue Falls
02/14 EXPRESS SCRIPTS HOLDING CO. : Regulation FD Disclosure, Financial Statements and..
02/14 EXPRESS SCRIPTS : beats 4Q profit forecasts
02/14 EXPRESS SCRIPTS : Announces 2016 Fourth Quarter and Full Year Results
02/14 EXPRESS SCRIPTS : Today
02/13 EXPRESS SCRIPTS : EpiPen alternative to hit market at more than seven times the ..
More news
Sector news : Drug Retailers - NEC
02/16DJRetail CEOs Meet With Trump Over Border Tax Concerns -- Update
02/15DJRetail CEOs Meet With Trump Over Border Tax Concerns
02/14 Exclusive - Trump to meet with retail CEOs on taxes, infrastructure
02/09DJCVS HEALTH : Profit Rises, Helped by Pharmacy Strength -- Update
02/09DJCVS HEALTH : Profit Rises, Helped by Pharmacy Strength
More sector news : Drug Retailers - NEC
4-Traders Strategies on EXPRESS SCRIPTS HOLDING CO 
2014Testing the USD 68.3 support
2013Trading opportunity
More Strategies
Latest Tweets
02/21Johnson Financial Group Inc. Acquires 1,483 Shares of Express Scripts Holding.. 
02/20Many insurers including Express Scripts, Unitedhealth Group and Cigna will no.. 
02/19Express Scripts Holding Company $ESRX Forecasted to Earn Q1 2017 Earnings of .. 
02/18Express Scripts Holding Company $ESRX Stake Held by Asset Planning Services L.. 
02/18Q1 2017 EPS Estimates for Express Scripts Holding Company Decreased by Oppenh.. 
More tweets
Qtime:129
News from SeekingAlpha
02/17 Tracking Glenn Greenberg's Brave Warrior Advisors Portfolio - Q4 2016 Update
02/15 Express Scripts, Inc. 2016 Q4 - Results - Earnings Call Slides
02/15 Express Scripts Holding (ESRX) Q4 2016 Results - Earnings Call Transcript
02/15 EXPRESS SCRIPTS : Prescription For Growth
02/15 Express Scripts' Wentworth takes issue with "misinformation" related to drug ..
Advertisement
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Full-screen chart
Technical analysis trends EXPRESS SCRIPTS H...
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 23
Average target price 80,7 $
Spread / Average Target 13%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Senior Vice President-Operations
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDIN..3.75%42 382
WALGREENS BOOTS ALLIAN..4.41%92 678
CVS HEALTH CORP1.08%81 738
MCKESSON CORPORATION7.43%31 861
CARDINAL HEALTH INC13.02%25 460
AMERISOURCEBERGEN CORP..16.40%19 720
More Results